CME Group Inc. (NASDAQ:CME - Get Free Report) CEO Terrence A. Duffy sold 40,000 shares of the stock in a transaction on Monday, April 29th. The stock was sold at an average price of $210.91, for a total value of $8,436,400.00. Following the completion of the transaction, the chief executive officer now owns 67,455 shares in the company, valued at $14,226,934.05. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
CME Group Trading Down 0.7 %
Shares of CME Group stock opened at $208.07 on Thursday. CME Group Inc. has a 1 year low of $175.73 and a 1 year high of $223.80. The firm has a market cap of $74.90 billion, a PE ratio of 23.67, a P/E/G ratio of 5.24 and a beta of 0.49. The stock has a fifty day moving average price of $214.51 and a 200-day moving average price of $211.67. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02.
CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.44 by $0.06. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The company had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.48 billion. During the same quarter last year, the firm posted $2.42 EPS. The firm's revenue for the quarter was up 3.2% on a year-over-year basis. Equities research analysts anticipate that CME Group Inc. will post 9.72 EPS for the current year.
CME Group Increases Dividend
[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks
From Crypto 101 Media | Ad
Are you monitoring 13,217 cryptocurrencies everyday?
If not, you could miss the ONE that can make you wealthy beyond your wildest dreams.
You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls.
Claim your free seat by clicking here now.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Investors of record on Friday, March 8th were issued a $1.15 dividend. The ex-dividend date of this dividend was Thursday, March 7th. This represents a $4.60 annualized dividend and a yield of 2.21%. This is a positive change from CME Group's previous quarterly dividend of $1.10. CME Group's dividend payout ratio (DPR) is 52.33%.
Institutional Investors Weigh In On CME Group
Several large investors have recently added to or reduced their stakes in CME. B. Riley Wealth Advisors Inc. boosted its stake in CME Group by 1.3% in the 4th quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider's stock worth $782,000 after purchasing an additional 48 shares during the period. Capital Advisors Ltd. LLC boosted its stake in CME Group by 4.3% in the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider's stock worth $250,000 after purchasing an additional 48 shares during the period. Lantz Financial LLC boosted its stake in CME Group by 1.1% in the 1st quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider's stock worth $982,000 after purchasing an additional 49 shares during the period. Transcend Capital Advisors LLC boosted its stake in CME Group by 1.7% in the 4th quarter. Transcend Capital Advisors LLC now owns 2,995 shares of the financial services provider's stock worth $631,000 after purchasing an additional 50 shares during the period. Finally, Jaffetilchin Investment Partners LLC boosted its stake in CME Group by 1.7% in the 3rd quarter. Jaffetilchin Investment Partners LLC now owns 3,022 shares of the financial services provider's stock worth $605,000 after purchasing an additional 51 shares during the period. Hedge funds and other institutional investors own 87.75% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities analysts recently issued reports on the company. Rosenblatt Securities reiterated a "sell" rating and issued a $187.00 target price (up from $185.00) on shares of CME Group in a report on Thursday, April 25th. Bank of America raised their price objective on CME Group from $209.00 to $216.00 and gave the company a "neutral" rating in a research note on Thursday, April 25th. Deutsche Bank Aktiengesellschaft restated a "hold" rating and set a $210.00 price objective (down from $235.00) on shares of CME Group in a research note on Friday, April 5th. Morgan Stanley raised their price objective on CME Group from $222.00 to $225.00 and gave the company an "equal weight" rating in a research note on Tuesday, April 9th. Finally, The Goldman Sachs Group cut CME Group from a "neutral" rating to a "sell" rating and set a $195.00 price objective on the stock. in a research note on Wednesday, January 3rd. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $217.80.
View Our Latest Analysis on CME
CME Group Company Profile
(
Get Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
